Title: Tamas Rujan - Innovator in Cancer Detection Technologies
Introduction
Tamas Rujan is an inventor based in Bottmingen, Switzerland. He has made significant contributions to the field of cancer detection, particularly in the areas of breast and ovarian cancer. Although he currently holds no granted patents, his work is focused on developing innovative methods for diagnosing and managing cancer.
Latest Patent Applications
Tamas Rujan's latest patent applications include:
1. **Method of Identifying Metastatic Breast Cancer by Differentially Methylated Regions** - This invention relates to methods for identifying the presence of DNA from metastatic breast cancer (mBC) cells in a sample from an individual. It also includes methods for diagnosing mBC and identifying patients with poor disease prognosis based on the presence of mBC cell DNA. Additionally, it involves oligonucleotide primers for amplifying differentially methylated regions (DMRs) and detection probes for identifying these regions.
2. **Epigenetic Markers and Related Methods and Means for the Detection and Management of Ovarian Cancer** - This invention focuses on methods for determining the presence or absence of ovarian cancer in women. It utilizes the detection of methylated or un-methylated CpGs associated with differentially methylated regions (DMRs) in cell-free DNA. The methods have diagnostic, prognostic, and predictive utility for managing ovarian cancer.
Conclusion
Tamas Rujan is a dedicated inventor whose work in cancer detection technologies holds promise for improving diagnostic methods and patient outcomes. His innovative approaches aim to enhance the understanding and management of breast and ovarian cancers.